According to a recent letter written in the South China Morning Post by Chien Wai-tong, a professor and the associate head (of research) in the school of nursing at Hong Kong Polytechnic University, one in about every four people in Hong Kong has been affected by a mental health issue at some point in his or her life, and the numbers keep going up. Unfortunately, though, mental illness is a taboo topic in most areas of the world, and China is no exception.
To raise awareness of mental health and encourage people with issues to get support and treatment, specifically in Hong Kong, Pfizer created Moodigo, a mobile app that enables users to track and share their mood via social media. For every mood/picture that is shared on Instagram, Moodigo donates $1 to the Mental Health Foundation in Hong Kong. The app also allows users to keep track of their sleep and fitness habits, since mental health can directly impact those activities. In addition, Moodigo contains a mental health quiz, as well as tips to help people feel better.
Pfizer clearly understands the power of the digital experience and the ability it has to engage patients, improve health, raise awareness, and, at the end of the day, sell more products. As life sciences companies become more familiar with the digital world and recognize just how vital it has become to effectively compete in the age of the consumer, we can expect to see more pharma, biotech, and medical device companies incorporating digital transformation into their business strategies.
For guidance on how to digitally transform your organization, contact us.
